[[Translated article]]Reflectance Confocal Microscopy Terminology in Spanish: A Delphi Consensus Study.

Consenso de terminología en microscopia confocal de reflectancia en español mediante método Delphi.
Basal cell carcinoma Carcinoma Basocelular Consenso Consensus MCR Melanoma Microscopía Confocal de Reflectancia Nomenclatura Nomenclature Reflectance confocal microscopy (RCM) Terminology Terminología melanoma

Journal

Actas dermo-sifiliograficas
ISSN: 1578-2190
Titre abrégé: Actas Dermosifiliogr
Pays: Spain
ID NLM: 0373062

Informations de publication

Date de publication:
18 Jan 2024
Historique:
received: 04 09 2023
accepted: 09 10 2023
medline: 21 1 2024
pubmed: 21 1 2024
entrez: 20 1 2024
Statut: aheadofprint

Résumé

The terminology used to describe reflectance confocal microscopy (RCM) findings in both melanocytic and nonmelanocytic lesions has been standardized in English. We convened a panel of Spanish-speaking RCM experts and used the Delphi method to seek consensus on which Spanish terms best describe RCM findings in this setting. The experts agreed on 52 terms: 28 for melanocytic lesions and 24 for nonmelanocytic lesions. The resulting terminology will facilitate homogenization, leading to a better understanding of structures, more standardized descriptions in clinical registries, and easier interpretation of clinical reports exchanged between dermatologists.

Identifiants

pubmed: 38244840
pii: S0001-7310(24)00034-6
doi: 10.1016/j.ad.2024.01.018
pii:
doi:

Types de publication

Practice Guideline

Langues

eng spa

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Publicado por Elsevier España, S.L.U.

Auteurs

A Abarzua-Araya (A)

Melanoma Unit, Dermatology Department, Pontificia Universidad Católica de Chile, Santiago, Chile; Melanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.

J Bañuls (J)

Dermatology Department, Hospital General Universitario de Alicante Dr. Balmis, ISABIAL, Alicante, Spain.

H Cabo (H)

Universidad de Buenos Aires, Buenos Aires, Argentina.

C Carrera (C)

Melanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain; CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain.

R Gamo (R)

Hospital Fundación Alcorcón, Madrid, Spain.

S González (S)

Department of Medicine and Medical Specialties, Alcalá de Henares University, Madrid, Spain.

Natalia Jaimes (N)

Dr Phillip Frost Department of Dermatology & Cutaneous Surgery, and Sylvester Comprehensive Cancer Center. University of Miami Miller School of Medicine, Miami, FL, United States.

C Navarrete-Dechent (C)

Melanoma Unit, Dermatology Department, Pontificia Universidad Católica de Chile, Santiago, Chile.

J Pérez (J)

Melanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.

R Roldán-Marín (R)

Clínica de Onco-dermatología, División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.

S Segura (S)

Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Universitat de Vic-Universitat central de Catalunya (UVIC), Spain.

O Yélamos (O)

Dermatology Department, Hospital de Santa Creu i Sant Pau de Barcelona, IIB SANT PAU, Universitat Autònoma de Barcelona, Barcelona, Spain.

S Puig (S)

Melanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain; CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. Electronic address: susipuig@gmail.com.

J Malvehy (J)

Melanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d' Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain; CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain.

Classifications MeSH